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Retinal dehydrogenase (RALDH) enzymatic activities catalyze the conversion of vitamin
A to its metabolite Retinoic acid (RA) in intestinal dendritic cells (DCs) and promote
immunological tolerance. However, precise understanding of the exogenous factors that
act as initial trigger of RALDH activity in these cells is still evolving. By using germ-free
(GF) mice raised on an antigen free (AF) elemental diet, we find that certain components
in diet are critically required to establish optimal RALDH expression and activity, most
prominently in small intestinal CD103+CD11b+ DCs (siLP-DCs) right from the beginning
of their lives. Surprisingly, systematic screens using modified diets devoid of individual
dietary components indicate that proteins, starch and minerals are dispensable for this
activity. On the other hand, in depth comparison between subtle differences in dietary
composition among different dietary regimes reveal that adequate glucose concentration
in diet is a critical determinant for establishing RALDH activity specifically in siLP-DCs.
Consequently, pre-treatment of siLP-DCs, and not mesenteric lymph node derived
MLNDCs with glucose, results in significant enhancement in the in vitro generation of
induced Regulatory T (iTreg) cells. Our findings reveal previously underappreciated role
of dietary glucose concentration in establishing regulatory properties in intestinal DCs,
thereby extending a potential therapeutic module against intestinal inflammation.
Keywords: retinal dehydrogenase (RALDH), regulatory T cells (Treg), dendritic cells (DCs), LP-DCs, retinoic acid
(RA), vitamin A, immune regulation, dietary glucose
INTRODUCTION
Intestinal dendritic cells (DCs) are critical for the initiation and regulation of innate and adaptive
immunity by delivering self or foreign antigens to T cells (1–3). The intestine is spontaneously
exposed to innumerable antigens comprising of intestinal microbes (4, 5) as well as dietary
components (6, 7). To maintain immune homeostasis, intestinal DCs regulate the balance between
the tolerogenic immune response by inducing CD4+Foxp3+ regulatory T cells (Treg cells) (8–10)
and the protective immune responses by inducing effector T cells (11, 12). Dysregulation of this
balance by harmful pathogens or dietary intake results in inflammatory disorders (13, 14), such as
inflammatory bowel disease (IBD) (15, 16), celiac disease (17) and food allergy (18).
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Intestinal DCs are located in the Peyer’s Patches (PPs),
mesenteric lymph nodes (MLNs) and lamina propria (LP) and
comprise cellular subsets that have different origins and functions
(1, 2, 19–23). Among these DC subtypes, intestinal CD103+ DCs
have the unique function that metabolizes vitamin A to retinoic
acid (RA) through the activation of aldehyde dehydrogenase 1,
member A2 [Aldh1a2, also called retinaldehyde dehydrogenase
(RALDH2)] enzyme (24, 25). The RA produced by intestinal
DCs play an important role in orchestrating immune responses;
imprinting gut-homing specificity on T cells, B cells and
innate lymphoid cells (ILCs), inducing IgA-producing B cells,
promoting TGF-β-dependent differentiation of induced Treg
cells, suppressing the differentiation of Th17 cells, enhancing IL-
22 production by γδ T cells and ILCs, as well as inducing effector
functions in T cells (26–39).
While vitamin A derived from dietary intake can induce
RALDH enzymatic activity, the RA produced from intestinal
epithelial cells (IECs) by RALDH1 and stroma cells in LP and
MLN by RALDH2, in a trans activating mechanism is also
capable of inducing RALDH expression in intestinal DCs (40–
44). Furthermore, recent data suggest that RA is also involved
in the development of a gut homing precursor for intestinal
DCs in the bone marrow as well as is required for their
transcriptional programming and maturation (45, 46). Several
endogenous factors that regulate RALDH expression in LP-
DCs are also reported. Cytokines such as IL-4 and granulocyte
macrophage colony-stimulating factor (GM-CSF) induce or
enhance the expression of RALDH enzymes in LP-DCs, while
prostaglandin E2 (PGE2) negatively regulates RALDH activity
through the induction of inducible cyclic AMP early repressor
(ICER) (24, 47–49). Despite these findings, whether additional
components in diet can induce RALDH activity in the intestine
and promote immune tolerance, remains unknown. In this study,
we uncover a hitherto unknown role of dietary glucose in shaping
up intestinal immunological tolerance by facilitating RALDH
expression specifically in intestinal LP-DCs.
RESULTS
Mice Administered Antigen Free Diet Have
Defects in Development and RALDH
Activity in CD103+CD11b+ siLP-DCs
To investigate the influence of commensal microbiota and food
components on intestinal immunity, we utilized the previously
established “Antigen free (AF)” mice model, where germ-free
(GF) mice are raised on well-defined elemental diet [termed
“Antigen free diet” (AFD)] devoid of macromolecules such as
proteins and starches (50). When DCs in small intestine were
assessed, we observed comparable frequencies of CD11c+MHC-
II+ siLP-DCs in specific pathogen free (SPF), GF and AF mice
(Figures 1A,B). However, in-depth analyses revealed alteration
in the frequencies of tolerogenic DC subtypes. The frequency
of CD103+CD11b+ siLP-DCs, a subset known to be a major
tolerogenic DC population, was slightly, but significantly lower
in AF, when compared to SPF and GF mice (Figure 1C). A
compensatory increase on the other hand was observed in
the CD103+CD11b− siLP-DC compartment. More interestingly,
while the expression of the characteristic DC surface markers
largely remained comparable in all three groups (Figure S1A),
the expression of all three representative genes tested, namely
Aldh1a2, Indoleamine-pyrrole 2,3-dioxygenase 1 (Ido1) and
Transforming growth factor beta 1 (Tgfb1) that are functionally
implicated in tolerogenic phenotype of CD103+CD11b+ DCs,
were dramatically reduced in AFmice (Figure 1D). Interestingly,
the expression of Aldh1a2 was found to be specifically reduced in
mice raised under AFD, a phenomenon that was not observed
in GF mice (Figure 1D, left panel). On the other hand, the
absence of gut microbiota appeared to partially influence the
expression of Ido1 and Tgfb1, which was further enhanced by
AFD (Figure 1D, middle and right panel). These results indicated
that certain dietary components, otherwise absent or under-
represented in AFD have most specific and the largest influence
on the expression ofAldh1a2. For this study, we therefore focused
on the influence of normal diet on RALDH activity in siLP-DCs.
RALDH is an enzyme that irreversibly metabolizes vitamin A
to RA, which in turn acts as a key modulator of mucosal immune
responses (38, 51–53). To determine whether in concert to its
reduced expression, the function of RALDH in LP-DCs from
AF mice was also negatively affected, we next examined RALDH
enzyme activity in LP-DCs from SPF, GF and AF mice using
the ALDEFLUOR assay. In this assay, which has been previously
employed in the context of CD103+ LP-DCs and MLN-DCs (43,
44), the RALDH enzyme activity is measured in individual cells
by flow cytometry with a fluorescent substrate based assay system
(54, 55). In agreement with the results obtained by real-time PCR
analysis, CD103+ siLP-DCs (both CD11b+ and CD11b− subsets)
from AFmice displayed significantly lower enzyme activity when
compared with SPF and GF mice (Figures 1E,F, Figure S1B). Of
note, the characteristic frequencies of the aforementioned siLP-
DC subtypes in SPF, GF and AF mice remained unaltered even
after performing this assay, suggesting that this enzyme assay did
not interfere with the phenotype of siLP-DCs (Figure S1C).
In order to further understand the role of dietary components
on RALDH activity, we next analyzed siLP-DC RALDH activity
in mice at different stages of their lives, after subjecting them to
specific dietary conditions. We observed that RALDH activity
in pre-weaned GF mice (2-3 weeks of age) was significantly
lower than in adult GF mice, and comparable to AF mice. This
was dramatically restored to the level equivalent to adult GF
mice within a week after weaning (Figure 2A). Furthermore,
when mice raised in AF condition were fed with Normal Chow
Diet (NCD), RALDH activity in CD103+CD11b+ siLP-DCs was
promptly recovered within a week (Figure 2B). Mirroring this,
an opposite phenomenon was observed when NCD in GF mice
was replaced with AFD (Figure 2C). These results suggested that
dietary component(s) in NCD, absent in AFD, is required as the
initial trigger for RALDH gene expression after mice are weaned,
thereby promoting enzyme activity as well as homeostasis of
CD103+CD11b+ siLP-DCs.
The above results also implied that supplementing AF mice
with RA, the final product of the enzymatic reaction and a known
feedback inducer of RALDH activity (40), would be sufficient in
driving RALDH activity in these mice. Indeed, when adult AF
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FIGURE 1 | Dietary intake affects differentiation and RALDH activity in CD103+ siLP-DCs. Cell suspensions were prepared from siLP harvested from age-matched
adult (6∼12-week-old) SPF, GF and AF mice and phenotypic and RALDH activity analyses of siLP-DCs were carried out. (A) Representative fluorescence-activated
(Continued)
Frontiers in Immunology | www.frontiersin.org 3 August 2020 | Volume 11 | Article 1897
Ko et al. Glucose Promotes siLP-DC RALDH Activity
FIGURE 1 | cell sorting (FACS) plots of siLP-DC subpopulations gated on Lin− (CD3−B220−) cells. (B) Statistical quantification of percentage (left) and total numbers
(right) of CD11c+MHC-II+ cells in mice from indicated experimental groups. (C) Graph displays percentage of siLP-DC subpopulations in CD11c+MHC-II+ cells. (B,C)
Data are combined from four independent experiments. (D) Real-time analyses of mRNA expression of indicated gene products normalized against Hprt mRNA levels.
(E,F) Representative FACS plots (left) and quantification (right) of relative mean fluorescence intensity (MFI) of aldefluor in CD103+CD11b+ (E) and CD103+CD11b−
(F) siLP-DC subpopulations from indicated groups. DEAB is a RALDH inhibitor. 1MFI is calculated by subtracting background (DEAB) MFI from aldefluor MFI. Relative
1MFI indicates ratio of 1MFI in experimental samples vs. control. Data are combined from six independent experiments. MEAN ± SEM are indicated. Statistical
significance was determined by one-way ANOVA (B,E,F) and two-way ANOVA (C) with Turkey’s multiple comparison tests. ****p < 0.0001, n.s., not statistically
significant.
mice were supplemented in their diet with RA, it resulted in
complete recovery of RALDH activity (Figure 2D). Interestingly
in all the cases, changes in RALDH activity also correlated
with the frequencies of CD103+CD11b+ siLP-DCs, suggesting
its role in differentiation as well as function of these cells. Of
note, while the above results were obtained in a GF setting, the
basic findings from these experiments could also be recapitulated
in mice raised in SPF conditions, thereby confirming that
mice with normal repertoire of gut flora are equally affected
by dietary components with respect to RALDH activity in
siLP-DCs (Figures S2A–C).
RALDH Activities in Different Intestinal
RA-Producing Cells Are Differentially
Affected by Diet
We next sorted to understand whether the influence of diet
on RALDH activity is an LP-DC specific phenomenon, or
whether other RALDH expressing cells are also affected. It
is well-established that within the gut associated lymphoid
tissues, besides LP-DCs, RA converting enzymes are also
expressed in LP associated stroma cells (LP-SCs), small intestine
epithelial cells (IECs), as well as MLN-DCs. The RA produced
from these cells, in particular IECs, is known as a local
source of RA for inducing the RALDH expression in CD103+
siLP-DCs (40–44).
The non-hematopoietic SCs in secondary lymph nodes
comprise three different cell types based on the expression
of surface markers. Lymphatic stroma cells [LSCs, also called
fibroblast reticular cells (FRC)], lymphatic endothelial cells
(LECs) and blood endothelial cells (BECs) (56, 57). Among
LP-SCs (CD45−EpCAM−) in small intestine, the LSCs that
expressed podoplanin (Pdpn) and are CD31−, were found
to be capable of activating RALDH enzymes (Figure 3A), as
previously reported (43). Interestingly, unlike LP-DCs, the
RALDH activity in LP-SCs remained comparable between GF
and AF mice (Figure 3B). In contrast, when IECs were analyzed,
the expression of Aldh1a1 (RALDH1), the major gene encoding
for RALDH enzyme in these cells, was found to be reduced
in AF mice (Figure 3C). Of note, while the IECs are well-
established to have RALDH activity (27, 58–61), the baseline of
this activity in these cells is known to be significantly lower than
LP-DCs (62, 63). Therefore, our attempt to measure RALDH
activity in IECs was unsuccessful due to lower sensitivity of
the ALDEFLUOR assay. However, albeit comparatively lower
RALDH activity on a per cell basis, the cumulative contribution
of IECs in RA production, is understandably of larger significance
since numerically there are many more IECs than the other cell
types in the intestine.
Finally, when MLN-DCs were analyzed, the RALDH activity
in particular within the CD103+CD11b+ DC population in AF
mice was found to be significantly, albeit to a lesser extent,
lower than that of GF mice (Figure 3D). Taken together these
results suggested that dietary components differentially influence
RALDH activity in different regulatory DC populations.
Whereas, MLN-DCs and IEC are affected, LP-SCs appeared to
remain unaffected from dietary contributions. These results also
implied that the overall reduction of RA synthesis cumulatively
among these cell types eventually contributed to the reduced
RALDH activity in the LP-DCs in AF mice.
Proteins, Starches, and Minerals in Diet Do
Not Influence RALDH Activity in
CD103+CD11b+ siLP-DCs
Since for this study we focused on RALDH activity in
siLP-DCs, we next wished to define which dietary factors
were required to trigger the initial RALDH activity in these
cells. While in our initial findings we observed both the
subtypes CD103+CD11b+ and CD103+CD11b− siLP-DCs to
have reduced RALDH activity in AF mice (Figures 1E,F), the
cell recovery of CD103+CD11b− siLP-DCs from SPF and GF
mice were low and the level of enzyme activity in this cell
type showed variability among individual mice (Figures 1C,F).
Therefore, henceforth in this study, we focused on the RALDH
activity in CD103+CD11b+ siLP-DCs.
We first confirmed that the reduction in RALDH activity
in CD103+CD11b+ siLP-DCs was not a consequence of low
Vitamin A content in AF diet, thereby compromising the
precursor for the assayed reaction. Based on information of
food compositions from the suppliers and from our pervious
report, final consumption of vitamin A per day by GF and
AF mice were comparable [Table S1 and (50)]. Nonetheless,
there remained a possibility that albeit equal consumption,
the absorption of vitamin A into the small intestine may be
compromised in AF mice. However, when GF mice were weaned
on AF diet supplemented with 10 times more vitamin A in
the usual form of “oil mix” or were administrated additional
“oil mix” by oral gavage, failed to recover the reduction in
RALDH activity in CD103+CD11b+ siLP-DCs (Figure S3).
We thus concluded that mere unavailability of the precursor
vitamin A was not a cause of reduced RALDH activity in
these cells.
To this end, we modified the compositions of purified
diet by removing individual food components (Table S2), with
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FIGURE 2 | Dietary components in normal chow readily trigger and maintain RALDH activity in siLP-DCs in mice after weaning. Cell suspensions prepared from siLP
were subjected to ALDEFLUOR assays and RALDH activity in CD103+CD11b+ siLP-DCs and percentage of siLP-DC subpopulations in CD11c+MHC-II+ cells were
analyzed by flow cytometry. (A) GF mice (3-weeks old) before weaning (pre-weaned), GF mice weaned onto NCD for 7 days and adult GF mice were analyzed. (B)
RALDH activity and frequencies of siLP-DC subpopulations in CD11c+MHC-II+ cells in adult AF mice (8∼12-week-old) after feeding NCD for 0, 1, 2, 4, 8, and 70+
days. (C) RALDH activity and frequencies of siLP-DC subpopulations in CD11c+MHC-II+ cells in adult GF mice (8∼12-week-old) after feeding AFD for 0, 1, 2, 4, 8,
and 11+ weeks. (D) RALDH activity and frequencies of siLP-DC subpopulations in CD11c+MHC-II+ cells in adult GF, AF, or AF mice that were administered intra
peritoneal injection of all-trans RA (500 µg per mouse in soybean oil) every other day for 7 days. Data are combined from two to three independent experiments.
MEAN ± SEM are indicated. (B,C) Statistical significance was determined by one-way ANOVA with Turkey’s multiple comparison test. **p < 0.01, ***p < 0.001, ****p
< 0.0001, n.s., not statistically significant.
the presumption that taking out or adding back individual
components in otherwise well-defined diet may lead us toward
identifying the dietary component required to trigger RALDH
activity. To obtain relatively accurate results under in vivo
settings, the modified diets were designed to contain similar
amount of vitamin A as in NCD (Tables S1, S2) and the
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FIGURE 3 | RALDH activity in intestinal RA-producing cells is differentially regulated by diet. (A–C) Cell suspensions from MLN and siLP harvested from age-matched
adult (6∼12-week-old) GF and AF mice were subjected to ALDEFLUOR assays and RALDH activity of LP-SCs and MLN-DCs were analyzed by flow cytometry. (A)
Representative FACS plot of LP-SC distinguished by CD31 and Pdpn from CD45-EpCAM- cells. Red dots in FACS plot indicate aldefluor positive cells. Histograms
depict the MFI of aldefluor in LP-SC subtypes. (B) Graph displays the level of RALDH activity in LSCs. Data is combined from two independent experiments. (C) IECs
were isolated from small intestine (SI) by stripping with EDTA and analyzed for expression of Aldh1a1 (RALDH1) by real-time PCR, upon normalization to Hprt mRNA
levels. Fold change indicates ratio target gene in experiment/control. Data are combined from four independent experiments. (D) Representative FACS plots of
MLN-DC subpopulations distinguished by CD103 and CD11b from CD11c+MHC-II+Lin− cells and the RALDH activity in CD103+CD11b+ MLN-DCs and
CD103+CD11b− MLN-DCs. Data are combined from four independent experiments. MEAN ± SEM are indicated. Statistical significance was determined by
two-tailed unpaired t-test. *p < 0.05, **p < 0.01, n.s., not statistically significant.
experiments were performed primarily in GF condition in order
to eliminate the influence of microbiota. In addition, to avoid
any influence from NCD during the pre-weaned period, neonate
AF mice were utilized and these mice were weaned onto each
modified diet for 3–4 weeks.
As a starting point, we took advantage of two commercially
available diets with well-defined dietary compositions. In the so-
called amino acid defined diet (AAD∗), like the AFD employed so
far, proteins were replaced with amino acids. However, there were
several differences between their compositions (Table S2). While
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FIGURE 4 | Depletion of macromolecules from purified diet do not alter the RALDH activity in CD103+CD11b+ siLP-DCs. AF mice (3∼4-week-old) were weaned onto
specific diets for 3∼4 weeks following which the indicated analyses were carried on. (A) A cartoon depicting experimental scheme (left panel). AAD* is a sterilized form
(Continued)
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FIGURE 4 | of Amino acid-defined diet (AAD) that contains three times more vitamin A than AAD, where protein macromolecules are replaced with amino acids.
AAD*_StF indicates AAD* from which cornstarch and maltodextrin are removed. The level of RALDH activity in CD103+CD11b+ siLP-DCs in the indicated groups are
presented by relative aldefluor 1MFI (right panel). (B) Representative FACS plots (left panel), frequencies (middle panel) and absolute numbers (right panel) of total
CD4+Foxp3+Treg cell and CD4+Foxp3+Nrp1lo peripheral Treg (pTreg) cell populations in siLP of mice subjected to the indicated diet regimes. (C) Experimental
scheme (left panel), and relative aldefluor 1MFI of siLP-DCs in the indicated experimental groups (right panel). Min_mix AFD indicates AFD mixing with the mineral mix
powder (TD.94049). Data are combined from four independent experiments. MEAN ± SEM are indicated. Statistical significance was determined by one-way ANOVA
with Turkey’s multiple comparison test, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s., not statistically significant.
AFD is a liquid diet where the fibers are provided as cellulose
bedding, AAD∗ diet are edible solid pellets with cellulose mixed
with the food components. Unlike AFD, AAD∗ diet contained
starches in the form of maltodextrin and corn starch, and while
the source of sugar in AFD was 22% glucose, that in AAD∗ was
37.1% sucrose. Furthermore, in terms of mineral composition,
there are substantial differences between the groups. The second
commercially available diet is AAD∗_StF, which was largely
similar to AAD∗, but was devoid of starches. Note, the “∗” in
AAD∗ indicates a sterilizable form of the diet which is otherwise
similar to its traditional form (AAD), but with three times more
vitamin A to account for presumed losses during sterilization by
irradiation. Surprisingly, the mice groups weaned in both AAD∗
and AAD∗_StF showed a complete recovery of RALDH activity
in CD103+CD11b+ siLP-DCs, to an extent similar to the control
NCD fed group (Figure 4A). These results were independent
of microbiota, since the characteristic drop in RALDH activity
of CD103+CD11b+ siLP-DCs in mice raised in SPF conditions
could also be recovered by AAD (Figure S2D). Taken together
these findings led to two important conclusions. First, starches
are not involved. Second, antigens in the form of peptides,
derived from proteins are also dispensable as far as RALDH
activity in CD103+CD11b+ siLP-DCs is concerned. To this end,
we also considered a possibility that an artifact arising from
unaccounted protein contamination in the amino acid defined
diets may be responsible for the observed recovery of RALDH
activity. We therefore quantified the generation of peripheral
Regulatory T (pTreg; also referred to as iTreg when induced
in vitro) cell population in the siLP of these mice. pTreg cells are
a type of Treg cells that are extrathymically generated primarily
at mucosal sites, and are distinguished from their thymic tTreg
counterparts by the lack of expression of the membrane bound
co-receptor neuropilin-1 (Nrp1) (64). Notably, in a previous
report we have demonstrated that diet derived proteins are the
primary cause for the generation of CD4+Foxp3+Nrp1− pTreg
cells in the small intestine (50), and AF mice display dramatically
reduced pTreg population in siLP. Indeed we found that while
total Foxp3+ Treg populations, comprising of tTreg and pTreg
cells, remained comparable, the frequencies and numbers of
Foxp3+Nrp1− pTreg cells among total Treg population could
only be recovered in mice fed with NCD, and not AAD∗
and AAD∗_StF (Figure 4B). Therefore, the recovery of RALDH
activity in AAD∗ and AAD∗_StF groups were not due to any
protein contamination in the AAD∗ diet.
We next wished to exclude the possibility that differences
in minor food components such as minerals, between AFD
and purified diet (Table S2), was responsible for differences in
RALDH activity. For that we prepared AFD by supplementing
with mineral mix powder (TD.94049) derived from AAD∗
(min_mix/AFD). As shown in Figure 4C, min_mix/AFD failed
to induce RALDH activity. Taken together, these results
concluded that proteins, starches and minerals in diet were
not responsible for the induction of RALDH activity in
CD103+CD11b+ siLP-DCs.
Optimum Glucose Level in Diet Is Required
To Induce RALDH Activity in
CD103+CD11b+ siLP-DCs
If the macromolecules and micromolecules in diet were not
involved, lack of which factors in AFD compromise RALDH
activity in CD103+CD11b+ siLP-DCs? To investigate further,
we compared the food compositions between AAD∗_StF and
AFD (Table S2), which were the closest among the four types
of diets tested. In case of AAD∗_StF, this diet does not contain
proteins and starches as in AFD, but does contain unknown
dietary factor(s) responsible for the induction of RALDH activity
in siLP-DCs. There are few differences between the composition
of these two diets; (1) the diet forms (pellet vs. liquid), (2) the
carbohydrate sources (sucrose vs. glucose), (3) the amount of
carbohydrate (sucrose ∼50% vs. glucose ∼22%). Based on this
observation, as well as in order to minimize the differences
in diet forms, we first generated a liquid form of AFD with
50% of sucrose (AFD_S500) or 50% glucose (AFD_G500).
Germ free diet (GFD) or AAD∗_StF were used as positive
controls. AFD with usual 22% glucose, designated as AFD_G220
here, was used as negative control. The neonate AF mice
were weaned onto each diet for 3–4 weeks and were analyzed
for RALDH activity in CD103+CD11b+ siLP-DCs (Figure 5A,
left panel). Indeed, AFD supplemented with 50% sucrose
resulted in significantly enhanced RALDH activity in these cells.
More interestingly, we observed a similar increase in RALDH
activity in CD103+CD11b+ siLP-DCs even when the source of
carbohydrate was changed to 50% glucose instead of sucrose
(Figure 5A, middle panel). These effects were found to be specific
for CD103+CD11b+ siLP-DCs, since RALDH1 expression in
IECs remained unaltered upon carbohydrate supplementation
(Figure 5A, right panel). These results suggested that regardless
of the source of carbohydrate, its optimum concentration
is important, and glucose being a monosaccharide unit of
carbohydrate is sufficient for the initial triggering of RALDH
activity in siLP-DCs.
In order to further understand whether the positive effect
of dietary carbohydrate supplementation is specific for RALDH
activity, or if it can also affect differentiation of other immune
cells, we determined the frequencies of Th1, Th2, and pTreg
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FIGURE 5 | Supplementing glucose in AF diet restores RALDH activity in CD103+CD11b+ siLP-DCs. (A) Cartoon depicting experimental scheme (left panel).
Neonate AF mice were weaned onto specific diets for 3∼4 weeks. AFD contains 22% of glucose (AFD_G220). AFD_G500 indicates 50% of glucose in AFD and
AFD_S500 indicates 50% of sucrose in AFD. AAD*_StF was utilized as a positive control of RALDH activity in LP-DCs. ALDEFLUOR assays were performed on cell
suspensions from siLP and RALDH activity of siLP-DC was analyzed by flow cytometry. The level of RALDH activity in CD103+CD11b+ siLP-DCs is represented as
relative 1MFI of aldefluor (middle panel). Aldh1a1 expression was also determined in sorted IECs relative to Hprt control (right panel). Data are combined from two
independent experiments. (B–D) Graphs display the percentage of Tbet+ in CD4+ T cells (Th1) (B), GATA3+ in CD4+ T cells (Th2) (C), and Nrp1lo populations among
in CD4+Foxp3+ Treg cells (pTreg) (D). Data are combined from at least two independent experiments. MEAN ± SEM are indicated. Statistical significance was
determined by one-way ANOVA with Turkey’s multiple comparison test, *p < 0.05, **p < 0.01, ****p < 0.0001, n.s., not statistically significant.
cells in these mice. Supplementation of AFD with additional
sucrose or glucose did not affect Tbet+ Th1 or Gata3+ Th2 cells
(Figures 5B,C); neither recovered the characteristically reduced
pTreg population in siLP (Figure 5D).
We next directly investigated the effect of glucose on RALDH
activity by employing in vitro culture conditions. SPL-DCs,
MLN-DCs, and CD11c+ siLP-DCs were magnetically purified
and cultured either without glucose (in commercially available
glucose-free media), without glucose but in the presence of RA,
with glucose, or in the presence of glucose and RA for 20 h,
and then measured for RALDH activity. In terms of base-line
RALDH activity, as expected, SPL-DCs displayed the least, which
was significantly increased in the presence of RA. Glucose, on
the other hand, had minimal effect (Figure 6A). Although MLN-
DCs had the highest base-line RALDH activity among the three
groups tested, neither RA nor glucose had an impact (Figure 6B).
In contrast, siLP-DCs derived from 2-weeks old neonatal SPF
mice which had low basal RALDH activity at steady state, was
significantly increased in the presence of glucose alone.While RA
itself induced slight increase of this enzyme activity, the highest
activity was observed when both RA and glucose was present
(Figure 6C). Moreover, this RALDH activity promoting effect of
glucose was also observed when siLP mixed lymphocytes derived
from 8-weeks old adult mice were cultured with glucose for 20 h.
Under the culture conditions tested, RA by itself was found to
haveminimal effect on the already high RALDH activity, whereas
the addition of glucose in the media was able to further boost this
activity (Figure 6D).
Finally, in order to ascertain functional relevance of these
findings, we sorted to determine whether supplementation
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FIGURE 6 | Glucose induces RALDH activity specifically in siLP-DCs. MLN-DCs and Spleen DCs (SPL-DC) from adult SPF mice, or siLP-DCs from 2-weeks old
neonatal SPF mice were either purified (A–C), or total single cell suspensions were isolated from adult SPF mice SI (D). Cells were cultured for 20 h in glucose-free
(Continued)
Frontiers in Immunology | www.frontiersin.org 10 August 2020 | Volume 11 | Article 1897
Ko et al. Glucose Promotes siLP-DC RALDH Activity
FIGURE 6 | media with or without treatments, following which ALDEFLUOR assay was performed. Fluorescence intensities of aldefluor in CD8−CD11b+ SPL-DCs
(A), CD103+ MLN-DCs (B) and CD103+CD11b+ siLP-DCs (C,D), were analyzed by flow cytometry. RALDH activity depicted in overlaid histograms and bar graphs
are from the cells cultured with glucose (22mM) or RA (1 nM) or both. The line graphs indicate RALDH activity from the cells cultured with different concentrations of
glucose (0, 11, 22, and 44mM) in the presence or absence of RA (1 nM). Data shown is representative of at least three independent experiments. MEAN ± SEM are
indicated. Statistical significance was determined by one-way ANOVA with Turkey’s multiple comparison test, *p < 0.05, **p < 0.01, ****p < 0.0001, n.s., not
statistically significant.
of glucose, presumably through the generation of RA, can
facilitate the generation of iTreg cells. For this, we performed
an in vitro iTreg induction assay with magnetically purified
CD11chi DCs (with “high” CD11c expression) that were pre-
treated with glucose and incubated with naïve T cells under
suboptimal iTreg inducing condition. We observed significant
increase in iTreg induction when siLP-DCs were pre-treated
with glucose, compared to mock. This effect of glucose pre-
treatment was specific for siLP-DCs, and was not observed
when MLN-DCs were used in the assay (Figures 7A,B and
Figure S4). These results, in accordance to the results presented
in Figure 6B, suggested that the siLP DCs are particularly
more susceptible to glucose treatment, and thereby, presumably
through enhanced RALDH activity, acquire superior iTreg cell
induction capacity compared to MLN DCs. It is to be noted
however, that while the purified CD11chiMHCII+ DCs used
in this assay are present in similar frequencies, there are
some site specific differences with regard to the expression
of MHCII and CD11c in MLN and siLP. Compared to siLP,
MLN has significantly higher proportion of CD11c−MHCII+
and CD11cintMCHII− (with “intermediate” CD11c expression)
populations (Figure S4, left panels). Furthermore, the expression
of MHCII in purified MLN DCs is lower than that of siLP
DCs (Figure S4, right panels). These observations raised the
formal possibility that enhanced MHCII expression in siLP,
rather than glucose mediated enhanced RALDH activity may
be responsible for increased iTreg conversion. However, pre-
treatment with RA, either alone or in the presence of glucose,
resulted in equally efficient iTreg induction irrespective of the
source of the DCs, suggesting that the benefit of glucose pre-
treatment is indeed primarily due to enhanced RA production
(Figures 7A,B). Lastly, when iTreg induction was carried out
in vitro in a DC independent manner, supplementation of
the media with excess glucose had little effect, thereby further
substantiating the role of DC derived RALDH in this process
(Figure S5).
DISCUSSION
There is accumulating evidence suggesting that vitamin A and its
metabolites play a pivotal role in maintaining various biological
processes (38, 52, 65–67). Dietary supplementation of RA in the
context of cutaneous T cell lymphoma and acute promyelocytic
leukemia, have been shown to have beneficial outcome (68–
71). Furthermore, many studies highlight anti-inflammatory
activities of RA at mucosal sites and tissues, such as intestinal
mucosa, airways, lung, central nervous system and skin (72–
82). In addition to the effect of RA on cancer and inflammatory
diseases, vitamin A or its metabolites play an important role
to suppress diet-induced obesity and insulin resistance (83–85).
Therefore, a better understanding of the cellular and molecular
parameters responsible for vitamin A metabolism is of great
biological relevance. In this study by identifying the role of diet,
and the importance of glucose consumption for establishing
RALDH activity early in life in small intestine DCs, we make
substantial contribution to our knowledge related to the role of
nutritional components in establishing immunological tolerance
at mucosal sites.
By feeding AF diet to mice raised under germ free condition
we found that small intestine CD103+CD11b+ LP-DCs require a
dietary component as an initial trigger for RALDH activity. Since
vitamin A in diet is known to be essential to activate RALDH
and generate RA in LP-DCs, LP-SCs, MLN-DCs, MLN-SCs, and
IECs (40, 43, 44), one explanation of this observation could be
the possibility that at steady state, AF mice consume less vitamin
A compared to GF mice raised on NCD. However, our further
experiments in conjunction with a previous report (50) strongly
indicate that the availability of vitamin A and the way it is fed
does not account for the low RALDH activity in AF mice. Even
supplementing large excess of vitamin A to AFD failed to restore
the reduction in RALDH activity in neonatal GF mice weaned
on AFD compared to NCD, suggesting that a possible inferior
intestinal absorption rate of vitamin A in AF mice is unlikely a
cause as well.
In order to define the responsible factor in diet, we employed
diet regimes with well-defined compositions. First, by weaning
neonate AF mice onto amino acid defined diet in which only
the proteins were replaced by defined concentration of amino
acids we found that protein macromolecules are dispensable.
This was a surprising finding andwas not due to any unaccounted
protein contamination in the AAD∗ diet, since the same diet
failed to induce small intestinal pTreg cells, a phenomenon
known to be dependent on peptide based antigen presentation.
Furthermore, subsequent experiments using defined diet regimes
eliminated starch and minerals as well. There are distinct
differences between the purified protein and starch free diet
AAD∗_StF and the AFD. First, the diet forms (pellet vs. liquid),
second the carbohydrate sources (sucrose vs. glucose) and third
the amount of carbohydrate (sucrose 50 vs. glucose 22%).
Since the forms of diet as well as the refinement status of
NCD can influence experimental outcome (86), we utilized
different types of diets (unrefined NCD, purified diets and
liquid form of diet) and compared between these groups. In
order to address the first issue, we generated a liquid form
of diet containing 50% of sucrose (AFD_S500) and compared
with the pellet form of AAD∗_StF containing around 50% of
sucrose. Irrespective of the diet types, both groups showed a
similar level of the RALDH activity in LP-DCs and it was
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FIGURE 7 | Pretreatment of glucose in siLP-DCs, but not in MLN-DC, significantly induce iTreg cells in vitro. siLP and MLN CD11c+ DCs were pre-cultured in
glucose-free media or media supplemented with 22mM glucose (Glu), 1nM RA, or with both glucose and RA. After 14 h the DCs were washed and co-cultured with
naïve CD4+ T cells under suboptimal Treg inducing condition. After 72 h Foxp3+ cells was analyzed by FACS. (A) Representative FACS plots. (B) Bar graphs
representing fold differences in Treg induction mediated by siLP-DC vs. MLN-DC. *P < 0.05. Data are representative of two independent experiments with similar
results.
significantly higher than AFD that contained 22% of glucose.
Sucrose is digested to fructose and glucose by the enzyme sucrase
that is secreted from the brush border of the small intestine.
Furthermore, a recent study reported that at a steady state,
most dietary fructose is metabolized and cleared by the small
intestine epithelial cells (87). It therefore appeared possible that
the metabolites from dietary fructose may have a role in RA
metabolism. However, when liquid diet containing 50% sucrose
(AFD_S500) vs. 50% glucose (AFD_G500) were compared, we
observed comparable RALDH induction; thereby indicating that
appropriate concentration of even a monosaccharide unit of
dietary glucose is sufficient to initiate RALDH activity in LPDCs.
Of note, while in these experiments the relative RALDH activities
were calculated on a per cell basis, the variations in total cells
obtained from intestinal lamina propria precluded us from
reliably calculating the absolute numbers of RALDH expressing
intestinal DCs in mice fed with the different dietary regimes.
Although the above experiments were performed primarily
on neonatal AF mice in germ free conditions, several lines
of evidence strongly suggested that these changes in RALDH
activity in response to dietary glucose is also apparent in SPF
mice comprised of normal gut microflora. First, while pre-
weaned SPF mice, like GF mice, displayed low RALDH activity
in siLP-DCs, its activity was increased when they were fed with
NCD after weaning. Second, and converse to this observation,
when adult SPF mice were fed with AFD (containing 22%
glucose) or pre-weaned SPF mice were weaned onto AFD, they
displayed significantly lower RALDH activity in siLP-DCs. Third,
this reduction in RALDH activity however was not observed
when SPF mice were weaned onto AAD, which has increased
carbohydrate content compared to AFD. Taken together these
results strongly suggest that the glucose dependent changes in
RALDH activity in siLP-DCs is still apparent inmice with normal
microbiome content and underscores the physiological relevance
of this study.
The composition of carbohydrate in NCD is approximately
44∼63% (SPFD and GFD) and 62∼67% in purified diets
(AIN-93G and AAD∗), which are significantly higher than the
carbohydrate content in mother’s milk (6.9–7.2% in human
and 3% in mouse) (88, 89). On the other hand, AFD contains
22% glucose which is 2.5-fold lower when compared to control
diets. The reason behind this is the fact that the glycemic
index (GI) of glucose (103 ± 3) is much higher than that
of sucrose (65 ± 4) and fructose (15 ± 4) (90). Therefore,
the percentage composition of glucose constituting AFD was
calculated by factoring in its GI as a parameter in order to
maintain mice healthy and capable of breeding. Indeed, from our
previous report and earlier studies (91–93), mice raised in AFD
were healthy and normal in size and weight, and displayed no
sign of nutritional deficiency. Despite these apparent normalcy
however, in this study we found that additional dietary source
of carbohydrate is required to trigger LP-DC RALDH activity in
AFD fed mice.
As a functional consequence we found that pre-treatment with
glucose results in enhanced iTreg inducing property specifically
in siLP-DCs in an in vitro assay system. This finding is in
concert with our previous finding where, in a OTII CD4+ T cell
transfer based in vivo assay we observed significantly reduced
pTreg generation in AF, compared to SPF and GF mice (50).
We propose that the primary cause of such reduced pTreg
conversion if AF mice despite being fed comparable amount of
OVA to that in SPF and GF mice, is the lower amount of dietary
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carbohydrate content in AFD. Taken together our study uncovers
the functional significance of minute refinements in dietary
compositions and underscores the fact that subtle differences in
diet may have significant influence on immune composition and
overall organismal physiology.
The role of glycolysis on DC physiology is well-appreciated
(94, 95). A recent study further suggests that the level of glucose
consumed is capable of reprograming glycolytic metabolism and
mitochondrial oxidative phosphorylation in lipopolysaccharide
(LPS)-stimulated DCs and repress pro-inflammatory responses
(96). The authors propose that the extent of glucose consumption
can control the expression of glucose transporters and glycolytic
enzymes by mammalian target of rapamycin complex 1
(mTORC1) / hypoxia-inducible factor 1a (HIF1a) / inducible
nitric oxide synthase (iNOS) signaling circuit (97–99). There
are several studies dating as far back to the late 1950’s that
point to a possible connection between glucose consumption and
vitamin A metabolism (100). In light of these previous reports,
in this study we have successfully established an unequivocal
role of dietary glucose consumption and RALDH activity in
LP-DCs and therefore intestinal tolerance. Precise molecular
nature of this connection, and how it affects specifically the LP-
DCs, remain less understood, and will be an active area of our
investigation in recent future. In sum, these findings significantly
enhance our knowledge on the crosstalk between functional
relationship between immune homeostasis and dietary intake
and expand our understanding of therapeutic strategies for
clinical applications.
MATERIALS AND METHODS
Mice
Specific pathogen-free (SPF) C57BL/6 (B6) mice were purchased
from The Jackson Laboratory and maintained in the animal
facility of POSTECHBiotech Center. A colony of Germ-free (GF)
B6 mice was established at POSTECH from breeders obtained
from Dr. Andrew Macpherson. GF B6 mice were maintained in
sterile flexible film isolators (Class Biological Clean Ltd., USA)
and GF status was regularly monitored by culturing feces of GF
mice. AF mice were generated and maintained in sterile flexible
film isolator as previously described (50). All animal studies
were performed in accordance with the guidelines of Institutional
Animal Care and Use Committee of POSTECH.
Mouse Diets
SPF diet (38057, Purina Lab) and GF diet (2018S, Envigo)
were used as normal chow diet (NCD) for the maintenance
of SPF and GF mice at the animal facility of POSTECH
Biotech Center. AF diet (AFD) was self-generated as previously
described (50). The custom diets were generated and supplied
from Envigo: amino acid-defined diet (AAD, TD.01084), AAD
with 3× vitamin A (AAD∗, TD.160107), starch deficient-AAD∗
(AAD∗_StF, TD.160108), and mineral mix powder (TD.94049).
AFD-based diets were self-generated as follows: 22% glucose in
AFD (AFD_G220, same as general AFD), 50% glucose in AFD
(AFD_G500) and 50% sucrose in AFD (AFD_S500).
Preparation and Processing of Single Cell
Suspensions From Small Intestine, MLN,
and Spleen
Single cell suspension from SI was prepared and processed as
previously described (50). In brief, SIs were dissected and opened
longitudinally after removal of Peyer’s patches. Tissues were cut
into pieces and incubated in PBS buffer containing 3% fetal
bovine serum (FBS), 10mM EDTA, 20mM HEPES, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 1mM sodium pyruvate
with gentle stirring at 37◦C for 20min to strip intestinal epithelial
cells (IECs). SI segments were collected by strainer for isolating
lamina propria lymphocytes and IECs in themedia were enriched
by 25–40 % Percoll density gradient centrifugation. Collected SI
segments were digested with 400 Mandl units/ml collagenase D
(Roche, Cat no. 11088882001) and 10µg/ml DNase I (Sigma,
04536282001) in RPMI 1640 containing 3% fetal bovine serum
(FBS), 20mM EDTA, 20mM HEPES, 100 U/ml penicillin, 100
mg/ml streptomycin, 1mM sodium pyruvate and 1mM Non-
essential amino acids at 37◦C for 45min with continuous stirring.
To stop the enzyme digestion, EDTA was added (10mM final
concentration) and cells were further incubated for 5min at
37◦C. Cell suspensions were enriched by 40–75% Percoll density
gradient centrifugation. MLNs and spleens were harvested and
minced with razor blade, followed by digesting at 37◦C for
20–30min with enzyme digestion buffer that were used for
SI cell preparation. For analysis of stroma cells from SI, the
enzyme digestions were repeated two more times with fresh
enzymes for 20min. The remaining procedures were same as SI
cell preparation.
ALDEFLUOR Assay and Flow Cytometry
Aldehyde dehydrogenate (ALDH) activity in individual cells
was measured using ALDEFLUOR kits (StemCell Technologies),
according to the manufacturer’s protocol with modifications.
Subsequently, aldefluor-reacted cells were stainedwith antibodies
and analyzed by flow cytometry. CD16/32 Fc Blocker (93, Cat.
No. 11302), CD3e-PerCp-Cy5.5 (145-2C11, Cat. No. 100328),
Thy1.2-PerCp-Cy5.5 (53-2.1, Cat. No. 140322), B220-PerCp-
Cy5.5 (RA3-6B2, Cat. No. 103236), NK1.1-PerCp-Cy5.5 (PK136,
Cat. No. 108728), MHC class II-eFluor 450 (M5/114.15.2,
Cat. No. 48-5321-82), CD11c-PE-Cy7 (N418, Cat. No. 25-
0114-82), CD103-PE (2E7, Cat. No. 12-1031-82), CD11b-
APC (M1/70, Cat. No. 17-0112-82), and CD8-BV650 (53-6.7,
Cat. No. 100742).
Fluorochrome-conjugated antibodies for single-cell staining
were purchased from BD Biosceineces, BioLegend, Thermo
Fisher Scientific and Tonbo Biosciences. For LP-DC phenotypic
analysis, cells were stained with antibodies and analyzed by flow
cytometry: CD16/32 Fc Blocker, CD3e-PerCp-Cy5.5, Thy1.2-
PerCp-Cy5.5, B220-PerCp-Cy5.5, NK1.1-PerCp-Cy5.5, CD11c-
PE-Cy7, MHC class II-APC-eFluor 780 (M5/114.15.2, Cat. No.
47-5321-82), CD103-BV510 (2E7, Cat. No. 121423) and CD11b-
FITC (M1/70, Cat. No.35-0112), Siglec-F-Alex Fluor 647 (E50-
2440, Cat. No. 562680), Ly6C-PB (HK1.4, Cat. No. 128014), and
CX3CR1-PE (SA011F11, Cat. No. 149006). For IECs and LP-SCs
analysis, cells were stained with CD45-PerCp-Cy5.5 (30-F11, Cat.
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No. 103132), EpCAM1-eFluor 450 (G8.8, Cat. No. 48-5791-82),
Pdpn-PE (8.1.1, Cat. No. 127408), and CD31-APC (390, Cat. No.
102410). For intracellular cytokine staining, cells were stimulated
with eBioscience cell stimulation cocktail plus protein transport
inhibitors (Thermo Fisher Scientific) for 4 h. Stimulated cells
were stained with antibodies for surface markers followed by
fixation and permeabilization with manufacturer’s instruction
(BD Biosciences). Intracellular staining with Foxp3, Tbet, and
GATA3 were performed by eBioscience Foxp3/Transcription
factor staining buffer set (Thermo Fisher Scientific): CD4-APC-
Cy7 (RM4-5, Cat. No. 25-0042), TCR-β-PE-Cy7 (H57-597, Cat.
No. 25-5961-82), CD44-eFluor 450 (IM7, Cat. No. 48-0441-
82), CD62L-FITC (MEL-14, Cat. No. 104406), Nrp-1-PE (3E12,
Cat. No. 145204), Foxp3-PE-Cy5.5 (FJK-16s, Cat. No. 35-5773-
82), GATA3-PE (TWAJ, Cat. No. 12-9966-42), Tbet-APC (4B10,
Cat. No. 644814). Dead cells were excluded by Ghost Dye
(Tonbo Biosciences) or Propidium iodide (PI, Sigma) staining.
Stained cells were analyzed by LSRFortessa or FACSCantoII
(BD Biosciences) and data were analyzed by FlowJo software
(Tree Star).
RNA Isolatio n and Real-Time PCR
CD11c+MHC-II+CD103+CD11b+ siLP-DCs were sorted with
a Moflo XDP (Beckman Coulter) and RNA was extracted using
TriZol (Invitrogen). IECs were obtained after stripping SI by
EDTA and RNA was extracted using RNeasy Mini kit (Qiagen)
or Hybrid-RTM (GeneAll). Complementary DNA was generated
using QuantiTect Reverse Transcription Kit (Qiagen) or Improm
II Reverse Transcriptase (Promega). Target messenger RNA was
quantified using SYBR green master mix (Applied Biosystems or
Takara) and gene specific primers in a duplex reaction with Hprt
(TaqMan gene expression assays, Thermo Fisher Scientific): Hprt
(Mm01545399_m1), (Aldh1a1 Mm00657317_m1), Aldh1a2
(Mm00501306_m1), Ido1 (Mm00492586_m1), and Tgfb1
(Mm01178820_m1). Data were analyzed on Applied Biosystems
ViiATM 7 Real-Time PCR system (Applied Biosystems) or Rotor-
Gene Q (Qiagen). Changes in gene expression were calculated
by the comparative CT method and fold changes were calculated
using 2−11Ct method.
In vitro Experiments
Common RPMI 1640 Medium (Gibco, 11875119) contains
11mM glucose, but RPMI 1640 Medium, no glucose (Gibco,
11879020) does not contain glucose. Retinoic acid (RA, Sigma)
and Glucose (Sigma) were treated to culture cells with a various
concentration. SiLP-DCs, MLN-DCs and SPL-DCs were purified
using anti-CD11c magnetic beads and MACS columns (Milteny
Biotec). Purified DCs and SI cell suspensions (2×105 per well in
a 96-well plate) were cultured in glucose-freemedia with different
concentration of glucose (0, 11, 22, and 44mM) in the presence
or absence of RA (1 nM). After overnight culture (20 h), cells
were analyzed for RALDH activity using ALDEFLUOR assay kit.
For in vitro Treg differentiation assay, DCs from siLP or MLN
were purified in the same way as above. Purified DCs (2 × 104
per well in a 96-well plate) were cultured in glucose-free media
with glucose (22mM) in the presence or absence of RA (1 nM)
for 14 h. Then, they were co-cultured with 2 × 105 naïve CD4+
T cells in the presence of 0.1µg/ml anti-CD3, 0.1 ng/ml TGFβ-
1 and 100U IL-2. Cultures were incubated for a total of 3 days
followed by FACS analysis.
Statistical Analyses
Mean and SEM values were calculated. Two-tailed unpaired
t-tests and one-way or two-way ANOVA with Turkey’s
multiple comparison test were performed, with GraphPad
Prism Software.
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Figure S1. Altered phenotype of siLP-DC subsets in AF mice. Cell suspensions from siLP were 
prepared from age-matched adult (6~12-week-old) SPF, GF and AF mice, following which phenotypic 
and RALDH activity analyses of siLP-DCs were carried out. (A) Representative histograms showing 
expression of indicated surface markers within CD103+CD11b+ siLP-DCs. Black lines indicate SPF, 
blue lines indicate GF and red lines indicate AF mice. (B) Statistical quantification for MFI of siLP-DC 
subsets. DEAB is a RALDH inhibitor. (C) Representative FACS plots (left) and statistical quantification 
(right) of siLP-DC subsets within Lin-CD11c+MHC-II+ cells after ALDEFLUOR assay. Lin- includes 
populations with no expression for CD3 and B220. Percentage and total numbers of CD11c+MHC-II+ 
cells and siLP-DC subsets are shown. Data shown are representative of 2-3 experiments. MEAN ± SEM 
are indicated. Statistical significance was determined by one-way ANOVA and two-way ANOVA with 
Turkey’s multiple comparison test. ****p < 0.0001, n.s., not statistically significant. 
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Figure S2. Dietary component mediated increase in RALDH activity in siLP-DCs in mice is 
independent of microbiota.  Cell suspensions prepared from siLP were subjected to ALDEFLUOR 
assays and RALDH activity in CD103+CD11b+ siLP-DCs were analyzed by flow cytometry. (A) Pre-
weaned SPF mice (3-weeks old), SPF mice weaned onto NCD for 7 days and adult SPF mice were 
analyzed. (B) RALDH activity in CD103+CD11b+ siLP-DCs from adult 8-12 weeks old SPF mice after 
feeding AFD for 0, 1, 2, and 8 weeks. (C) RALDH activity in CD103+CD11b+ siLP-DCs in adult SPF 
mice at the start of the experiment, after they were fed AFD for 8 weeks, and after the mice were 
reverted back to NCD for one week. (D) SPF mice were weaned onto AFD (22% glucose) or AAD (50% 
sucrose) for 4 weeks. MEAN ± SEM are indicated. Statistical significance was determined by one-way 
ANOVA with Turkey’s multiple comparison test. *p < 0.05, ****p < 0.0001, n.s., not statistically 
significant. 
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Figure S3. Supplementing AFD even with large excess of Vitamin A is unable to restore RALDH 
activity in CD103+CD11b+ siLP-DCs. Neonate GF mice (3-week-old) were weaned onto specific diets 
for 3~4 weeks. Normal AFD comprises of water soluble dietary components in water and water 
insoluble dietary components (including vitamin A) in soybean oil-mix. AFD(10xVitA) indicates mice 
fed with oil-mix containing 10 times more of vitamin A than normal AFD. AFD+VitA(G) indicates mice 
administrated with oil-mix (300 μl) by oral gavage for 9 days under normal AFD feeding condition. Cell 
suspensions from siLP were subjected to ALDEFLUOR assays and RADLH activity in CD103+CD11b+ 
siLP-DCs was analyzed. Data are combined from two or three independent experiments. MEAN ± SEM 
are indicated. Statistical significance was determined by one-way ANOVA with Turkey’s multiple 
comparison test. ****p < 0.0001, n.s., not statistically significant. 
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Figure S4. Purity of MLN and siLP DCs used for in vitro iTreg assay. CD11c mediated 
magnetic purification was performed from wild type C57BL/6 mice using commercially available 
purification kit.  
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Figure S5. Glucose supplementation in a DC independent culture has little effect on in vitro iTreg 
induction. Sorted naïve T cells were subjected to DC independent iTreg induction with plate bound anti-
CD3/ CD28, TGFβ and IL2, in the presence (22mM) or absence (mock) of excess glucose for three days. 
Representative FACS plots (left) and statistics (right) are shown. n.s., not statistically significant. 
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Table S1. Vitamin A concentrations among different diet types 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Harlan-Teklad
    (2018s)
AIM/IBS
(Kim et al. 2016)Supplier
Vitamin A (IU/g)
Final consumption
of Vitamin A per day
SPFD GFD AFD
Purina Lab.
    38057
28 30 104
56 IU/2g    ~ 30 IU/2g
 (after autoclave)
~ 31.2 IU/300 ul
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Table S2. Comparison between food compositions of different modified diet types 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
